Product Images Oxaliplatin

This is a description of Oxaliplatin, a cytotoxic agent, and its packaging. It is a sterile aqueous solution, preservative-free, with 50mg/10mL concentration of Oxaliplatin. It comes in a 1x10mL single-dose vial, to be administered only through intravenous use. The medication should not be mixed or added to sodium chloride/chloride-containing solutions. It comes with a package insert that indicates directions for required dilution. It is distributed by Fosun Pharma USA and made in India. The storage temperature should be at 20° to 25°C, with excursions permitted between 15° and 30°C. The medication should be protected from light and should not be frozen. *

This is a description of a medication called Oxaliplatin. It is an injection used intravenously as a cytotoxic agent, supplied in a 10mL single-dose vial. It can only be used with specific solutions, and is not to be mixed with sodium chloride/chloride-containing solutions. The medicine is distributed by Fosun Pharma USA Inc., based in Princeton, NJ, and has been made in India. The text also displays the drug's code number, batch number, and a barcode with the GTIN00372266161017 code.*

This text describes a medication called Oxaliplatin, which is a cytotoxic agent that is administered intravenously. The medication comes in a single-dose vial of 20 mL and should not be mixed with sodium chloride/chloride-containing solutions. The medication is stored at controlled room temperature (20-25°C) and must be protected from light. The package contains a package insert that provides further instructions and necessary dilution. Dosage and administration should be done as per the instructions given in the package, and the solution should not be frozen or reused once opened. It is manufactured by FOSUNPHARMA and made in India.*

This appears to be a graph displaying the percentage of patients surviving over a period of months. The treatments being compared are "lati plas 5FU/LY" and "irinotecan plus SFU/LY". The notation "p<0.0001*" suggests that the difference between the survival rates of the two treatments is statistically significant. The remaining text may be a reference to a statistical test used to compare the survival rates (Lo rank test). However, the output is not legible and may contain errors.*